The 2026 findings
What changed in ten years of papers on lab animals. Each finding sets 2021 to 2025 against 2011 to 2015.
Updated November 12, 2026.
150,161 papers named a strain, stock, model or engineered line in 2021 to 2025, 110,577 of them a strain, stock or model
1.1 times as many as in 2011 to 2015
26 of 78 strains, stocks and models compared were named in at least 5% more papers in 2021 to 2025 than in 2011 to 2015, and 46 in at least 5% fewer
Compared: the strains, stocks and models with 100 papers or more in one period and 10 or more in each. A substrain's papers count toward its parent strain.
8 findings
A finding stays on this page only while the data support it.
C57BL/6 passed Sprague-Dawley as the strain papers name most
Papers in each period
- C57BL/6 1.6 times as many
- 2011 to 2015
- 17,670
- 2021 to 2025
- 28,313
- Sprague-Dawley about the same
- 2011 to 2015
- 18,340
- 2021 to 2025
- 18,394
Sprague-Dawley led in 2011 to 2015 with 18,340 papers.
C57BL/6 led in 2021 to 2025 with 28,313 papers.
Mice gained papers while rats lost them
Papers in each period
- Mouse 1.4 times as many
- 2011 to 2015
- 255,811
- 2021 to 2025
- 349,291
- Rat 10% fewer
- 2011 to 2015
- 153,182
- 2021 to 2025
- 137,802
Papers on mice: 1.4 times as many.
Papers on rats: 10% fewer.
18 times as many papers name CRISPR near a word for a lab animal
Papers in each period
- CRISPR-made 18 times as many
- 2011 to 2015
- 208
- 2021 to 2025
- 3,640
From 208 papers in 2011 to 2015 to 3,640 in 2021 to 2025, on any species.
A paper counts when it names CRISPR near a word for the animal, so papers that used CRISPR on mouse or rat cells, not to make animals, count too.
Of the 78 strains compared, 5xFAD gained papers fastest
Papers in each period
- 5xFAD 7.7 times as many
- 2011 to 2015
- 170
- 2021 to 2025
- 1,315
- APP/PS1 2.7 times as many
- 2011 to 2015
- 733
- 2021 to 2025
- 1,966
- Tg2576 64% fewer
- 2011 to 2015
- 387
- 2021 to 2025
- 141
Among the strains, stocks and models with 100 papers or more in one period and 10 or more in each, 5xFAD, a mouse model of Alzheimer's disease, grew fastest: 7.7 times as many papers.
APP/PS1: 2.7 times as many papers. Tg2576: 64% fewer papers.
NSG mice gained papers while SCID and NOD/SCID mice lost them
Papers in each period
- NSG 1.8 times as many
- 2011 to 2015
- 442
- 2021 to 2025
- 812
- SCID mouse 62% fewer
- 2011 to 2015
- 1,195
- 2021 to 2025
- 457
- NOD/SCID 50% fewer
- 2011 to 2015
- 1,007
- 2021 to 2025
- 501
NSG: 1.8 times as many papers.
SCID: 62% fewer papers. NOD/SCID: 50% fewer papers.
Cre-lox lines gained papers while transgenic lines lost them
Papers in each period
- Cre-lox 1.6 times as many
- 2011 to 2015
- 4,203
- 2021 to 2025
- 6,537
- Transgenic 32% fewer
- 2011 to 2015
- 15,717
- 2021 to 2025
- 10,651
Cre-lox: 1.6 times as many papers.
Transgenic: 32% fewer papers.
Zebrafish papers nearly doubled
Papers in each period
- Zebrafish 1.9 times as many
- 2011 to 2015
- 10,576
- 2021 to 2025
- 19,889
From 10,576 papers in 2011 to 2015 to 19,889 in 2021 to 2025: 1.9 times as many.
Papers naming a strain or line grew more slowly than papers on lab animals
Papers in each period
- Papers on lab animals 1.2 times as many
- 2011 to 2015
- 496,368
- 2021 to 2025
- 597,770
- Papers that name a strain or line 1.1 times as many
- 2011 to 2015
- 138,387
- 2021 to 2025
- 150,161
Papers on lab animals: 1.2 times as many.
Papers that name a strain, stock, model or engineered line: 1.1 times as many.
Their share of animal papers went from 27.9% to 25.1%.
More data
Strains
How strains are used
Species and animal numbers
About the data
Counts are papers in PubMed, with species and research areas from PubTator 3. Courtesy of the U.S. National Library of Medicine. NLM has not endorsed these pages or ConductColony. How we count, downloads and attributions.